Skip to main content

Table 2 Types of Skin Rash in Apalutamide-treated Patients

From: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study

Analysis Set (N = 68)

Total

n (%)

Grade 1

n (%)

Grade 2

n (%)

Grade 3

n (%)

Rash

35 (51.47)

9 (13.23)

16 (23.52)

10 (14.70)

 Rash

13 (19.11)

8 (11.76)

4 (5.88)

1 (1.47)

 Rash maculo-papular

11 (16.17)

2 (2.94)

6 (8.2)

3 (4.41)

 Rash generalised

11 (16.17)

1 (1.47)

7 (10.29)

3 (4.41)

 Erythema multiforme

3 (4.41)

0

1 (1.47)

2 (2.94)

 Stomatitis

3 (4.41)

1 (1.47)

2 (2.94)

0

 Urticaria

2 (2.94)

2 (2.94)

0

0

 Blister

1 (1.47)

1 (1.47)

0

0

 Drug eruption

1 (1.47)

0

0

1 (1.47)

 Rash macular

1 (1.47)

0

0

1 (1.47)

 Skin erosion

1 (1.47)

1 (1.47)

0

0

 Skin exfoliation

1 (1.47)

1 (1.47)

0

0